HTB

ICAAC 45th Washingon 2005

Pharmacology and drug interaction studies in adults: summary table from CROI, ICAAC and EACS conferences

45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA

One third of HIV/HCV coinfected patients with normal ALT have advanced fibrosis in Spanish cohort

45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA

Understanding TMC114 power against resistant HIV

New antiretroviral compounds at ICAAC: new PI brecanavir from GSK; maturation inhibitor PA-457; antiviral activity of monoclonal antibody; TNX-355 in treatment experienced patients

Comparison of pharmacokinetics of originator and generic liquid formulations and split tablets in Malawian children

African-Americans in ACTG 5095 had shorter time to virologic failure and grade 3/4 side effects

Predictors of insulin resistance in first year of therapy

Three measures confirm 144-week renal record of tenofovir

Low rash risk with efavirenz after nevirapine rash